Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids‐DOTT trial): pilot/feasibility phase findings
Neil A. Goldenberg(Johns Hopkins University), Ayesha Zia, Guy Young(Children's Hospital of Los Angeles), Mindy Simpson(Indiana Hemophilia and Thrombosis Center), B. Mitchell(University of Colorado Denver), John M. Kittelson(University of Arizona), Patrick J. Blatchford(Colorado School of Public Health), Michael Recht(McMaster University), Nicholas Stence(Colorado School of Public Health), Alex C. Spyropoulos(Lenox Hill Hospital), Lakshmi Srivaths(McMaster University), Roshni Kulkarni(Mayo Clinic), Sanjay Ahuja(McMaster University), Courtney D. Thornburg(McMaster University), Craig M. Kessler(Georgetown University), Laura Z. Fenton(University of Colorado Anschutz Medical Campus), Marcela Torres(McMaster University), Madhvi Rajpurkar(McMaster University), Julie Jaffray(University of Colorado Anschutz Medical Campus), Nyah Shah(McMaster University), Sarah H. O’Brien(Nationwide Children's Hospital), Cristina Tarango(McMaster University), Christine Knoll(McMaster University), Thomas C. Abshire(Medical College of Wisconsin), Yaser Diab, Nicole Verdun(Center for Biologics Evaluation and Research), Janna M. Journeycake(University of Oklahoma Health Sciences Center), Shannon L. Carpenter(Children's Mercy Hospital), Rowena C. Punzalan(McMaster University), Alison Geddis, Marilyn J. Manco‐Johnson(University of Colorado Anschutz Medical Campus), Sam Schulman(Thrombosis and Atherosclerosis Research Institute), Kristina M. Haley(Oregon Health & Science University), M. Wang(McMaster University), Jonathan L. Halperin(Icahn School of Medicine at Mount Sinai), Sahana D. Acharya(McMaster University), William R. Hiatt(Meridian Clinical Research), Alexander G.G. Turpie(McMaster University), Nicole Kucine(McMaster University), C. Takemoto(McMaster University), Philippe Gabríel Steg(Mount Sinai Hospital)
Cited by 66
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
|Journal of Thrombosis and Haemostasis|2005|4.9k